BridgeBio Oncology Therapeutics (BBOT)
0 followers
BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. Initially formed as a subsidiary of BridgeBio, BridgeBio Oncology Therapeutics completed a $200M private financ... Read more
Org chart
Eli Wallace
Chief Executive Officer
Eli Wallace
Collapse
Pedro J. Beltran
Chief Scientific Officer
Howard Chang
Vice President, Operations
Raymond Kelleher
Director
Scott Platshon
Board Observer
Similar companies
ARS Pharmaceuticals
1 follower
Cybrexa Therapeutics
1 follower
Forge Biologics
2 followers
Vaxcyte
2 followers
Kyverna Therapeutics
5 followers
Ventyx Biosciences
1 follower
Edgewise Therapeutics
1 follower
iECURE
1 follower
Amgen
186 followers
Thermo Fisher Scientific
149 followers
Gilead Sciences
122 followers
Discover companies